Menu
Search
|

Menu

Close
X

PolarityTE Inc COOL.OQ (NASDAQ Stock Exchange Capital Market)

38.73 USD
-0.24 (-0.62%)
As of Jun 22
chart
Previous Close 38.97
Open 39.59
Volume 1,349,018
3m Avg Volume 115,118
Today’s High 40.17
Today’s Low 37.08
52 Week High 41.19
52 Week Low 15.35
Shares Outstanding (mil) 18.49
Market Capitalization (mil) 716.08
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
1
FY15
7
EPS (USD)
FY18
-3.776
FY17
-26.016
FY16
-9.903
FY15
-5.320
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
11.56
Price to Sales (TTM)
vs sector
44,754.73
2.83
Price to Book (MRQ)
vs sector
17.52
2.19
Price to Cash Flow (TTM)
vs sector
--
14.29
Total Debt to Equity (MRQ)
vs sector
0.00
14.95
LT Debt to Equity (MRQ)
vs sector
0.00
8.61
Return on Investment (TTM)
vs sector
-171.65
18.31
Return on Equity (TTM)
vs sector
--
19.57

EXECUTIVE LEADERSHIP

Denver Lough
Chairman of the Board, Chief Executive Officer, Chief Scientific Officer, Since 2016
Salary: --
Bonus: --
John Stetson
President, Chief Investment Officer, Director, Since 2018
Salary: $151,385.00
Bonus: --
Paul Mann
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Edward Swanson
Chief Operating Officer, Director, Since 2016
Salary: --
Bonus: --
Holly Kramen
Chief Compliance Officer and Privacy Officer, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Technology
Industry: Internet Services
Address:

1960 S 4250 W
SALT LAKE CITY   UT   84104-4836

Phone: +1385.2372279

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.

SPONSORED STORIES